- SHL Announces Full-Year 2023 Results - Stable Revenue Growth Alongside Groundbreaking Clinical Milestones
- Imperial College London Study Shows Groundbreaking Final Results for SHL Telemedicine’s SmartHeart® in Post-ACS Patient Care
- SHL Telemedicine’s SmartHeart® Technology Triumphs in US Army Project Convergence – Capstone 4 Experiment
- SHL Telemedicine: Invitation to Conference Call Presenting Annual Results 2023
- SHL Telemedicine Receives Buy Rating with $11.00 Price Target
More ▼
Key statistics
On Thursday, SHL Telemedicine Ltd (SHLTN:SWX) closed at 4.71, 34.57% above the 52 week low of 3.50 set on Apr 30, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 5.10 |
---|---|
High | 5.22 |
Low | 4.71 |
Bid | 4.65 |
Offer | 5.22 |
Previous close | 4.70 |
Average volume | 10.61k |
---|---|
Shares outstanding | 16.39m |
Free float | 8.68m |
P/E (TTM) | -- |
Market cap | 77.46m CHF |
EPS (TTM) | -0.3953 CHF |
Data delayed at least 15 minutes, as of May 16 2024.
More ▼